PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PT. SOHO Industri Pharmasi - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12342
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine and antiallergy, antihyperlipidaemic, antipsychotic, antiviral, corticosteroid, h2 blocker, proton pump inhibitor, hepatoprotector, immunomodulator, musculoskeletal and osteoporosis, neurotropic and neurotonic, oral antidiabetic, sweetener, and vitamins. It products are used in the therapeutic areas of allergy and asthma, arthritis and bone infection, childrens’s growth, dermatitis, constipation, diabetes mellitus, ear, nose and throat infection, hyperacidity and immune system, among others. The company manufactures products in the forms of tablets, sugar coated, film-coated, capsules, syrup, caplets, injection, cream, gels, solution and suppositories of GMP. PT SOHO is headquartered in Jakarta, Indonesia.

PT. SOHO Industri Pharmasi – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Cumberland Pharma Enters Into Licensing Agreement With SOHO Industri Pharmasi For Caldolor 10
Equity Offering 11
Gamma Vaccines Raises Additional Funds in Private Placement 11
Gamma Vaccines Raises Additional Funds in Private Placement 12
Gamma Vaccines Raises Funds in Private Placement of Shares 13
Acquisition 14
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 14
PT. SOHO Industri Pharmasi – Key Competitors 15
PT. SOHO Industri Pharmasi – Key Employees 16
PT. SOHO Industri Pharmasi – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Key Facts 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Deals By Therapy Area, 2012 to YTD 2018 8
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cumberland Pharma Enters Into Licensing Agreement With SOHO Industri Pharmasi For Caldolor 10
Gamma Vaccines Raises Additional Funds in Private Placement 11
Gamma Vaccines Raises Additional Funds in Private Placement 12
Gamma Vaccines Raises Funds in Private Placement of Shares 13
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 14
PT. SOHO Industri Pharmasi, Key Competitors 15
PT. SOHO Industri Pharmasi, Key Employees 16

List of Figures
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kier Group Plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group Plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Carmanah Technologies Corporation:企業の戦略的SWOT分析
    Carmanah Technologies Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Schneider Electric SE:企業の戦略・SWOT・財務情報
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Topy Industries Ltd:企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Jardine Lloyd Thompson Group plc:企業の戦略・SWOT・財務分析
    Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report Summary Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Merit Medical Systems Inc (MMSI):医療機器:M&Aディール及び事業提携情報
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Inter Parfums SA:企業の戦略・SWOT・財務情報
    Inter Parfums SA - Strategy, SWOT and Corporate Finance Report Summary Inter Parfums SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Guyana Goldfields Inc:企業の戦略・SWOT・財務情報
    Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report Summary Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務分析
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務情報
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析
    Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Scatec Solar ASA (SSO):電力:M&Aディール及び事業提携情報
    Summary Scatec Solar ASA (Scatec Solar) is an integrated independent producer of solar power that develops, builds, owns and operates solar power plants. It conducts project origination and development, project financing, design and engineering, procurement and construction management, operation and …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Walvax Biotechnology Co Ltd (300142):製薬・医療:M&Aディール及び事業提携情報
    Summary Walvax Biotechnology Co Ltd (Walvax) is a biopharmaceutical company that develops, produces and markets bio-medical products including vaccines and blood products. The company's products include haemophilus influenzae vaccine for the prevention of infectious diseases such as meningitis. Walv …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lowe’s Companies, Inc.:戦略・SWOT・企業財務分析
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Polydex Pharmaceuticals Ltd (POLXF):企業の財務・戦略的SWOT分析
    Summary Polydex Pharmaceuticals Ltd (PPL) is a manufacturer and marketer of pharmaceutical intermediates for human and veterinary pharmaceutical markets. The company manufactures and sells bulk quantities of dextran and derivative products. Its dextran and its derivatives can be used as adjuvants, e …
  • Huntington Ingalls Industries Inc:戦略・SWOT・企業財務分析
    Huntington Ingalls Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Huntington Ingalls Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆